US Global Investors Funds’s Biogen BIIB Stock Holding History

US Global Investors Funds’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$2.38M	Buy	+8,500	New	+$2.2M	0.43%	80

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

US Global Investors Funds's BIIB Position: Q4 2013 in Review

US Global Investors Funds opened a new position in Biogen (BIIB) in Q4 2013: 8,500 shares worth $2.38M. The stake represents 0.43% of the portfolio and ranks #80 among its holdings.

739 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

US Global Investors Funds held 8,500 shares of Biogen worth $2.38M as of Q4 2013.
Biogen was a new US Global Investors Funds position in Q4 2013.
Biogen made up 0.43% of US Global Investors Funds's portfolio in Q4 2013, its #80 holding.
739 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.